1255 Impact of immune checkpoint inhibitors on bone turnover in cancer patients: prospective clinical study and preclinical correlates

Tamara Gassner; Sonia Vallet; Christina Chittilappilly; Theo Pirich; Judith Lind; Osman Aksoy; Vincent Sunder-Plassmann; Klaus Hackner; Elisabeth Zwickl-Traxler; Peter Errhalt; Martin Pecherstorfer; Klaus Podar

doi:10.1136/jitc-2022-SITC2022.1255

1255 Impact of immune checkpoint inhibitors on bone turnover in cancer patients: prospective clinical study and preclinical correlates

Tamara Gassner, Sonia Vallet, Christina Chittilappilly, Theo Pirich, Judith Lind, Osman Aksoy, Vincent Sunder-Plassmann, Klaus Hackner, Elisabeth Zwickl-Traxler, Peter Errhalt, Martin Pecherstorfer, Klaus Podar

Research output: Journal article (peer-reviewed) › Conference contribution to journal

Original language	English
Pages (from-to)	A1300-A1300
Journal	Journal for ImmunoTherapy of Cancer
DOIs	https://doi.org/10.1136/jitc-2022-SITC2022.1255
Publication status	Published - 2022

Access to Document

10.1136/jitc-2022-SITC2022.1255

https://jitc.bmj.com/lookup/doi/10.1136/jitc-2022-SITC2022.1255

Untersuchung der Effekte von Immun-Checkpoint Inhibitoren auf den Knochenumbau.
Vallet, S. (PI)
Forschungsimpulse
01.11.2021 → 30.11.2023
Project: Forschungsimpulse › Seed Funding
BONE: Biomarker- based therapeutic prevention of bone metastases in breast cancer: Defining the pathophysiologic impact of the endosteal niche
Vallet, S. (PI)
Forschungsimpulse
01.08.2020 → 31.12.2023
Project: Forschungsimpulse › Research Time Out (RTO)

Cite this

Gassner, T., Vallet, S., Chittilappilly, C., Pirich, T., Lind, J., Aksoy, O., Sunder-Plassmann, V., Hackner, K., Zwickl-Traxler, E., Errhalt, P., Pecherstorfer, M., & Podar, K. (2022). 1255 Impact of immune checkpoint inhibitors on bone turnover in cancer patients: prospective clinical study and preclinical correlates. Journal for ImmunoTherapy of Cancer, A1300-A1300. https://doi.org/10.1136/jitc-2022-SITC2022.1255

@article{ae03e99e88be49159b44062f7a315382,

title = "1255 Impact of immune checkpoint inhibitors on bone turnover in cancer patients: prospective clinical study and preclinical correlates",

author = "Tamara Gassner and Sonia Vallet and Christina Chittilappilly and Theo Pirich and Judith Lind and Osman Aksoy and Vincent Sunder-Plassmann and Klaus Hackner and Elisabeth Zwickl-Traxler and Peter Errhalt and Martin Pecherstorfer and Klaus Podar",

year = "2022",

doi = "10.1136/jitc-2022-SITC2022.1255",

language = "English",

pages = "A1300--A1300",

journal = "Journal for ImmunoTherapy of Cancer",

issn = "2051-1426",

publisher = "BMJ Publishing Group",

}

Gassner, T , Vallet, S , Chittilappilly, C , Pirich, T , Lind, J , Aksoy, O , Sunder-Plassmann, V , Hackner, K , Zwickl-Traxler, E , Errhalt, P , Pecherstorfer, M & Podar, K 2022, '1255 Impact of immune checkpoint inhibitors on bone turnover in cancer patients: prospective clinical study and preclinical correlates', Journal for ImmunoTherapy of Cancer, pp. A1300-A1300. https://doi.org/10.1136/jitc-2022-SITC2022.1255

TY - JOUR

T1 - 1255 Impact of immune checkpoint inhibitors on bone turnover in cancer patients: prospective clinical study and preclinical correlates

AU - Gassner, Tamara

AU - Vallet, Sonia

AU - Chittilappilly, Christina

AU - Pirich, Theo

AU - Lind, Judith

AU - Aksoy, Osman

AU - Sunder-Plassmann, Vincent

AU - Hackner, Klaus

AU - Zwickl-Traxler, Elisabeth

AU - Errhalt, Peter

AU - Pecherstorfer, Martin

AU - Podar, Klaus

PY - 2022

Y1 - 2022

U2 - 10.1136/jitc-2022-SITC2022.1255

DO - 10.1136/jitc-2022-SITC2022.1255

M3 - Conference contribution to journal

SN - 2051-1426

SP - A1300-A1300

JO - Journal for ImmunoTherapy of Cancer

JF - Journal for ImmunoTherapy of Cancer

ER -

1255 Impact of immune checkpoint inhibitors on bone turnover in cancer patients: prospective clinical study and preclinical correlates

Access to Document

Projects

Untersuchung der Effekte von Immun-Checkpoint Inhibitoren auf den Knochenumbau.

BONE: Biomarker- based therapeutic prevention of bone metastases in breast cancer: Defining the pathophysiologic impact of the endosteal niche

Cite this